| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | +9.4% | +0.1% |
| R&D Expense | $1.2M | +8.2% | -31.8% |
| SG&A Expense | $8.4M | -19.6% | -26.3% |
| Operating Income | $60.7M | +169.9% | +562.1% |
| Pre-tax Income | $61.1M | +166.3% | +587.0% |
| Income Tax | $7.5M | +433.1% | +3168.7% |
| Net Income | $53.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.1M | -5.7% | -9.4% |
| Current Assets | $58.8M | +6.2% | +3.6% |
| Total Assets | $420.4M | +16.9% | +32.5% |
| Current Liabilities | $34.6M | -3.7% | +119.0% |
| Total Liabilities | $180.0M | +3.0% | +1.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | +44.7% | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | -$3.3M | -22.7% | — |
| Financing Cash Flow | -$1.5M | -141.3% | — |
| Free Cash Flow | -$1.7M | +44.7% | — |
| +112.6% |
| +519.4% |
| EPS (Basic) | $2.86 | +111.9% | +514.5% |
| EPS (Diluted) | $2.86 | +111.9% | +514.5% |
| $240.3M |
| +30.1% |
| +72.8% |